export const patentsPortfolioData = [
  {
    inventor: "Contrary",
    industry: "Medical",
    title: "Personal protective equipment and method",
    abstract: "123",
    date: "YYYY-MM-DD",
  },
  {
    inventor: "Contrary",
    industry: "Medical",
    title: "Personal protective equipment and method",
    abstract: "123",
    date: "YYYY-MM-DD",
  },
  {
    inventor: "Contrary",
    industry: "Medical",
    title: "Personal protective equipment and method",
    abstract: "123",
    date: "YYYY-MM-DD",
  },
  {
    inventor: "Contrary",
    industry: "Medical",
    title: "Personal protective equipment and method",
    abstract: "123",
    date: "YYYY-MM-DD",
  },
];

export const fundingAPIData = [
  {
    id: "1",
    funder: "International Monetary Fund",
    location: "Washington, D.C., US",
    paper: "123",
    industry: "Medical",
    funding: "$34.1B",
  },
  {
    id: "2",
    funder: "International Monetary Fund",
    location: "Washington, D.C., US",
    paper: "123",
    industry: "Medical",
    funding: "$34.1B",
  },
  {
    id: "3",
    funder: "International Monetary Fund",
    location: "Washington, D.C., US",
    paper: "123",
    industry: "Medical",
    funding: "$34.1B",
  },
  {
    id: "4",
    funder: "International Monetary Fund",
    location: "Washington, D.C., US",
    paper: "123",
    industry: "Medical",
    funding: "$34.1B",
  },
];

export const expertsAPIData = [
  {
    id: "1",
    inventor: "Riccardo Privolizzi",
    affiliation: "University College London",
    location: "Washington, D.C., US",
    patents: "32 ",
    papers: "123",
  },
  {
    id: "2",
    inventor: "Riccardo Privolizzi",
    affiliation: "University College London",
    location: "Washington, D.C., US",
    patents: "32 ",
    papers: "123",
  },
  {
    id: "3",
    inventor: "Riccardo Privolizzi",
    affiliation: "University College London",
    location: "Washington, D.C., US",
    patents: "32 ",
    papers: "123",
  },
  {
    id: "4",
    inventor: "Riccardo Privolizzi",
    affiliation: "University College London",
    location: "Washington, D.C., US",
    patents: "32 ",
    papers: "123",
  },
];

export const publicationsAPIData = [
  {
    title:
      "Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres",
    description:
      "To our knowledge, no previous study has assessed the performance of a rapid antigen diagnostic immunoassay (RAD) conducted at the point of care (POC). We evaluated the Panbio™ COVID-19 Ag Rapid Test Device for diagnosis of coronavirus 2019 disease (COVID-19) in symptomatic patients (n = 412) attending primary healthcare centers.",
    id: 1,
  },
  {
    title:
      "Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres",
    description:
      "To our knowledge, no previous study has assessed the performance of a rapid antigen diagnostic immunoassay (RAD) conducted at the point of care (POC). We evaluated the Panbio™ COVID-19 Ag Rapid Test Device for diagnosis of coronavirus 2019 disease (COVID-19) in symptomatic patients (n = 412) attending primary healthcare centers.",
    id: 2,
  },
  {
    title:
      "Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres",
    description:
      "To our knowledge, no previous study has assessed the performance of a rapid antigen diagnostic immunoassay (RAD) conducted at the point of care (POC). We evaluated the Panbio™ COVID-19 Ag Rapid Test Device for diagnosis of coronavirus 2019 disease (COVID-19) in symptomatic patients (n = 412) attending primary healthcare centers.",
    id: 3,
  },
  {
    title:
      "Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres",
    description:
      "To our knowledge, no previous study has assessed the performance of a rapid antigen diagnostic immunoassay (RAD) conducted at the point of care (POC). We evaluated the Panbio™ COVID-19 Ag Rapid Test Device for diagnosis of coronavirus 2019 disease (COVID-19) in symptomatic patients (n = 412) attending primary healthcare centers.",
    id: 4,
  },
  {
    title:
      "Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres",
    description:
      "To our knowledge, no previous study has assessed the performance of a rapid antigen diagnostic immunoassay (RAD) conducted at the point of care (POC). We evaluated the Panbio™ COVID-19 Ag Rapid Test Device for diagnosis of coronavirus 2019 disease (COVID-19) in symptomatic patients (n = 412) attending primary healthcare centers.",
    id: 5,
  },
];
